Three-dimensional radiation treatment planning: Principles and practice

Onkologie

Volumn 21, Issue 6, 1998, Pages 474-484

  Zimmermann, F B ^a   Molls, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

3 D radiation treatment planning; Conformal radiation therapy

Indexed keywords

BRAIN TUMOR; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DOSIMETRY; HUMAN; LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT POSITIONING; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; REVIEW; SIMULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

EID: 0032414512     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026890     Document Type: Review

References (72)

1. Sailer SL, Tepper JE: Clinical implications of new innovations in radiation treatment delivery. Semin Radiat Oncol 1995;5:166-171.
2. Vijayakumar S, Chen GT: Implementation of three-dimensional conformal radiation therapy: Prospects, opportunities, and challenges. Int J Radiat Oncol Biol Phys 1995;33:979-983.
3. Corn BW, Hanks GE, Schultheiss TE, Hunt MA, Lee WR, Coia LR: Conformal treatment of prostate cancer with improved targeting: Superior prostate-specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys 1995;32:325-330.
4. Pollack A, Zagars GK, Starkschall G, Childress CH, Kopplin S, Boyer AL, Rosen II: Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 1996;34:555-564.
5. Byhardt RW: The evaluation of radiation therapy oncology group (RTOG) protocols for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1995;32: 1513-1525.
6. Forman JD, Duclos M, Shamsa F, Porter AT, Orton C: Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: Results of a dose escalation study. Int J Radiat Oncol Biol Phys 1996;34:655-662.
7. Purdy JA: Defining our goals: Volume and dose specification for 3-D conformal radiation therapy. Front Radiat Ther Oncol 1996;29:24-30.
8. Kagawa K, Lee WR, Schultheiss TE, Hunt MA, Shaer AH, Hanks GE: Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;38:319-325.
9. Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M, Flentje M: Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995;33:455-460.
10. Pardo FS, Aronen HJ, Kennedy D, Moulton G, Paiva K, Okunieff P, Schmidt EV, Hochberg FH, Harsh GR, Fischman AJ: Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. Int J Radiat Oncol Biol Phys 1994;30:663-669.
11. Schad LR, Boesecke R, Schlegel W, Hartmann GH, Sturm V, Strauss LG, Lorenz WJ: Three-dimensional image correlation of CT, MR, and PET studies in radiotherapy treatment planning of brain tumors. J Comput Assist Tomogr 1987;11:948-954.
12. Seither RB, Jose B, Paris KJ, Lindberg RD, Spanos WJ: Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging. Am J Clin Oncol 1995;18:297-299.
13. Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, Reidel G, Ziegler SI, Lumenta C, Molls M, Schwaiger M: Fluorine-18-FDG-PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 1997;38: 802-808.
14. Fraass BA, McShan DL, Kessler ML: Computer-controlled treatment delivery. Semin Radiat Oncol 1995;5:77-85.
15. Beard CJ, Kijewski P, Bussiere M, Gelman R, Gladstone D, Shaffer K, Plunkett M, Castello P, Coleman CN: Analysis of prostate and seminal vesicle motion: Implications for treatment planning. Int J Radiat Oncol Biol Phys 1996;34:451-458.
16. Verhey LJ: Immobilizing and positioning patients for radiotherapy. Semin Radiat Oncol 1995;5: 100-114.
17. Fischer JJ, Moulder JE: The steepness of the dose-response curve in radiation therapy. Radiology 1975;117:179-184.
18. Grosu AL, Stärk S, Feldmann HJ, Kneschaurek P, Leonardi M, Lumenta C, Molls M: Stereotaktische Konvergenzbestrahlung am Linearbeschleuniger - Bildgebung, Technik und klinische Indikationen. Röntgenpraxis 1998;51:9-15.
19. Rosenthal SJ, Gall KP, Jackson M, Thornton AF Jr: A precision cranial immobilization system for conformal stereotactic fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:1239-1245.
20. Leibel SA, Armstrong JG, Kutcher GJ, Zelefsky MJ, Burman CM, Mohan R, Ling CC, Fuks Z: 3-D conformal radiation therapy for non-small cell lung cancer. Front Radiat Ther Oncol 1996;29:199-206.
21. Emami B, Purdy JA, Manolis J, Barest G, Cheng E, Coia L, Doppke K, Galvin J, LoSasso T, Matthews J, Munzenrider J, Shank B: Three-dimensional treatment planning for lung cancer. Int J Radiat Oncol Biol Phys 1991;21:217-227.
22. Leibel SA, Kutcher GJ, Zelefsky MJ, Burman CM, Mohan R, Ling CC, Fuks Z: 3-D conformal radiotherapy for carcinoma of the prostate. Front Radiat Ther Oncol 1996;29:229-237.
23. Armstrong JG, Zelefsky MJ, Leibel SA, Burman C, Han C, Harrison LB, Kutcher GJ, Fuks ZY: Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 1995;6:693-697.
24. Drzymala RE, Mohan R, Brewster MS, Chu J, Goitein M, Harms W, Urie M: Dose-volume histograms. Int J Radiat Oncol Biol Phys 1991;21:71-78.
25. Kessler ML, Ten Haken RK, Fraass BA, McShan DL: Expanding the use and effectiveness of dose-volume histograms for 3-D treatment planning I: Integration of 3-D dose display. Int J Radiat Oncol Biol Phys 1994;29:1125-1131.
26. Martel MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS: Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 1994;28:575-581.
27. Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R: Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991;21:137-146.
28. Lyman JT, Wolbarst AB: Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 1987;13:103-109.
29. eff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 1993;27:689-695.
30. Lee WR, Hanks GE, Hanlon AL, Schultheiss TE, Hunt MA: Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1996;35:251-257.
31. Thornton AF, Hegarty TJ, Ten Haken RK, Yanke BR, La Vigne ML, Fraass BA, McShan DL, Greenberg HS: Three-dimensional treatment planning of astrocytomas: A dosimetric study of cerebral irradiation. Int J Radiat Oncol Biol Phys 1991; 1309-1315.
32. Grosu AL, Feldmann HJ, Albrecht C, Kneschaurek P, Wehrmann R, Groß MW, Zimmermann FB, Molls M: 3-dimensional radiation treatment planning in brain tumors: Advantages and clinical results. Strahlenther Onkol 1998;174:7-13.
33. Emami B, Lyman J, Brown A, Coia L, Goiten M, Munzenrider J, Shank B, Solin LJ, Wesson M: Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
34. Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M: Malignant glioma: Patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994;30:146-149.
35. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30: 907-911.
36. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment of glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-1409.
37. Nakagawa K, Aoki Y, Fujimaki T, Tago M, Terahara A, Karasawa K, Sakata K, Sasaki Y, Matsutani M, Akanuma A: High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998;40:1141-1149.
38. Sandler HM: 3-D conformal radiotherapy for brain tumors. The University of Michigan Experience. Front Radiat Ther Oncol 1996;29:250-254.
39. Pu AT, Sandler HM, Radany EH, Blaivas M, Page MA, Greenberg HS, Junck L, Ross DA: Low grade gliomas' preliminary analysis of failure patterns among patients treated using 3D conformal external beam irradiation. Int J Radiat Oncol Biol Phys 1995;31:461-466.
40. Kim HK, Thornton AF, Greenberg HS, Page MA, Junck L, Sandler HM: Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol 1997; 20:358-363.
41. Kolotas C, Birn G, Baltas D, Rogge B, Ulrich P, Zamboglou N: CT based interstitial high dose rate brachytherapy for recurrent malignant gliomas. Br J Radiol 1998 (accepted for publication).
42. Prados MD, Gutin PH, Phillips TL, Wara WM, Sneed PK, Larson DA, Lamb SA, Ham B, Malec MK, Wilson CB: Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience. Int J Radiat Oncol Biol Phys 1992;24:593-597.
43. Wen PY, Alexander E III, Black PM, Fine HA, Riese N, Levin JM, Coleman CN, Loeffler JS: Long-term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 1994;73:3029-3036.
44. Sneed PK, Gutin PH, Larson DA, Malec MK, Phillips TL, Prados MD, Scharfen CO, Weaver KA, Wara WM: Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 1994; 29:719-727.
45. Oldham M, Neal A, Webb S: A comparison of conventional 'forward planning' with inverse planning for 3D conformal radiotherapy of the prostate. Radiother Oncol 1995;35:248-262.
46. Perez CA, Stanley K, Rubin P, Kramer S, Brady L, Perez-Tamayo R, Brown GS, Concannon J, Rotman M, Seydel HG: A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1980;45:2744-2753.
47. Graham MV, Purdy JA, Emami B, Harms W, Matthews J: 3-D conformal radiotherapy for lung cancer. Front Radiat Ther Oncol 1996;29:188-198.
48. Zimmermann FB, Molls M, Kneschaurek P, Pietzsch C: 3-D-Planung bei der Radiotherapie des Bronchialkarzinoms. Onkologe 1995;5:467-474.
49. Schraube P, von Kampen M, Oetzel D, Sroka G, Wannenmacher M: The impact of 3-D radiotherapy planning after a pneumonectomy compared to a conventional treatment set-up. Radiother Oncol 1995;37:65-70.
50. Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, Littles JF, Martinez FJ, Francis IR, Quint LE, Lichter AS: Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1079-1085.
51. Hazuka MB, Turrisi AT, Lutz ST, Martel MK, Ten Haken RK, Strawderman M, Borema PL, Lichter AS: Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27:273-284.
52. Hanks GE, Martz KL, Diamond JJ: The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988:15:1299-1305.
53. Hanks GE, Schultheiss TE, Hunt MA, Epstein B: Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1994;31:25-29.
54. Hanks GE, Lee WR, Hanlon AL, Hunt M, Kaplan E, Epstein BE, Movsas B, Schultheiss TE: Conformal technique dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys 1996;35:861-868.
55. Sandler HM: 3-D conformal radiotherapy for prostate cancer. The University of Michigan experience. Front Radiat Ther Oncol 1996;29:238-243.
56. Zierhut D, Flentje M, Sroka-Perez G, Rudat V, Engenhart-Cabillic R, Wannenmacher M: The conformal radiotherapy of localized prostatic carcinoma: Acute tolerance and early efficacy. Strahlenther Onkol 1997;173:98-105.
57. Soffen EM, Hanks GE, Hunt MA, Epstein BE: Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: A reduction in acute morbidity. Int J Radiat Oncol Biol Phys 1992;24:485-488.
58. Hanks GE, Schultheiss TE, Hanlon AL, Hunt M, Lee WR, Epstein BE, Coia LR: Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. Int J Radiat Oncol Biol Phys 1997;37:543-550.
59. D'Amico AV, Coleman CN: Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: The jury is still out. J Clin Oncol 1996;14:304-315.
60. Wallner K, Roy J, Harrison L: Tumor control and morbidity following transperineal iodine-125 implementation for stage T1/T2 prostatic carcinoma. J Clin Oncol 1996;14:449-453.
61. Levitt SH, Khan FM, Higgins PD, Nierengarten MB: Cost-benefit analysis of 3 D conformal radiation therapy. Strahlenther Onkol 1997;173:441-443.
62. Perez CA, Michalski J, Ballard S, Drzymala R, Kobeissi BJ, Lockett MA, Wasserman TH: Cost benefit of emerging technology in localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;39:875-883.
63. Kolitsi Z, Dahl O, Van Loon R, Drouard J, Van Dijk J, Ruden BI, Chierego G, Rosenwald JC: Quality assurance in conformal radiotherapy: DYNARAD consensus report on practice guidelines. Radiother Oncol 1997;45:217-223.
64. Thwaites D, Scalliet P, Leer JW, Overgaard J: Quality assurance in radiotherapy. Radiother Oncol 1995;35: 61-73.
65. Armstrong JG: Three-dimensional conformal radiotherapy. Precision treatment of lung cancer. Chest Surg Clin N Am 1994;4:29-43.
66. Rosenman J: 3-D treatment planning for brain tumors. Front Radiat Ther Oncol 1996;29:244-249.
67. Wachter S, Gerstner N, Dieckmann K, Stampfer M, Hawliczek R, Poetter R: Planned 3-dimensional low-volume conformal irradiation of a local prostatic carcinoma. Strahlenther Onkol 1997;173:253-260.
68. Zelefsky MJ, Aschkenasy E, Kelsen S, Leibel SA: Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1997:39:327-333.
69. Derycke S, Van Duyse B, De Gersem W, De Wagter C, De Neve W: Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer. Radiother Oncol 1997;45:253-261.
70. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR: Dose escalation without elective nodal irradiation is indicated in stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1996;36 (suppl):348.
71. Gross MW, Weber WA, Feldmann HJ, Bartenstein P, Schwaiger M, Molls M: The value of F-18 fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. Int J Radiat Oncol Biol Phys 1998;41:(in press).
72. Ling CC, Burman C, Chui CS, Kutcher GJ, Leibel SA, LoSasso T, Mohan R, Bortfeld T, Reinstein L, Spiron S, Wang XH, Wu Q, Zelefsky M, Fuks Z: Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996;35:721-730.